istopmm logo

Prevalence of multiple myeloma precursors revealed for the first time with iStopMM results

Researchers at iStopMM have for the first time described the prevalence of smoldering multiple myeloma and the findings indicate that it is present in 0.5% of people over 40. The high prevalence of smoldering multiple myeloma has implications for future treatment policies in multiple myeloma because people with this precursor condition, in cases where it […]

Sæmundur Rögnvaldsson MD, PhD

Sæmundur Rögnvaldsson a long-time member of the iStopMM core team defended his doctoral thesis Monoclonal gammopathy of what significance? Overcoming the methodological limitations of studying an asymptomatic precursor disorder on the 10th of October at the University of Iceland. Opponents were Dr. Angela Dispenzieri, professor at the Mayo Clinic and Dr. Lárus Steinþór Guðmundsson, associate […]

iStopMM team member receives IMS Young Investigator Award

We are proud to announce that a PhD student at the University of Iceland and a member of the iStopMM team Jón Þórir Óskarsson was awarded the IMS Young Investigator Award for Exemplary Abstract at the 19th International Myeloma Society Annual Meeting in Los Angeles for the abstract: Detection of Abnormal Plasma Cells by Multiparameter Flow Cytometry in […]

Major grant from the European Research Council (ERC) for further research on multiple myeloma

Sigurdur Yngvi Kristinsson professor of hematology at the University of Iceland Faculty of Medicine, specialist at Landspitali University Hospital and iStopMM´s principal investigator has been awarded a grant of EUR 2 million, the equivalent of around ISK 290 million, from the European Research Council (ERC) in order to focus on smoldering myeloma in the project […]

Dr. Kristinsson receives a large project grant from the Icelandic Centre for Research for the next three years

Sigurður Yngvi Kristinsson, principal investigator of iStopMM, received a large project grant from the Icelandic Centre for Research (RANNIS) for the next three years for the project “Screening for Waldenström macroglobulinemia (WM) and its precursors in an entire nation.” The grant provides a unique opportunity to further investigate the data that has been collected in iStopMM, […]

High prevalence of smoldering myeloma observed in nationwide screening study

In an article in the iStopMM study and it‘s results are covered. Results from the study were presented at the 2021 American Society of Hematology (ASH) Annual Meeting in december. Sigrun Thorsteinsdottir, MD, PhD of The University of Iceland from the iStopMM research team says: “These results underline the necessity for improved risk stratification […]

Icelandic healthcare registries have a very high accuracy

Many of the planned studies from the iStopMM project use data on disease diagnoses in the Icelandic healthcare registries. In this paper published in the Scandinavian Journal of Public Health, the accuracy of these diagnoses was assessed and was estimated to be 98.5%, confirming the validity and accuracy of these registries for future studies. The […]